type-2-diabetes

Documents about type-2-diabetes

• Digital Health Interventions for Diabetes Distress in Type 2 Diabetes: Protocol for a Scoping Literature Review Focused on Equity and Inclusion.#140458NCBI PubMed Central
• Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin#160327ClinicalTrials.gov
• Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population#140932ClinicalTrials.gov
• Effectiveness of Dapagliflozin for Weight Loss#18536ClinicalTrials.gov
• High Protein Breakfast on Appetite, Postprandial Glycemia and Weight Loss in T2D#18795ClinicalTrials.gov
• Whey Protein Ingestion and Glucose Control in Pre- and Post Diabetic Individuals#123671ClinicalTrials.gov
• Bioenergetics and Metabolism in Pediatric Populations#126096ClinicalTrials.gov
• Curcumin Supplement in Nonalcoholic Fatty Liver Patients#127760ClinicalTrials.gov
• The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients#140947ClinicalTrials.gov
• Screening, Brief Intervention, and Referral to Treatment in Primary Care#141194ClinicalTrials.gov
• Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital#141199ClinicalTrials.gov
• Molecular Mechanisms and Carotid Atherosclerosis#143778ClinicalTrials.gov
• Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque#143788ClinicalTrials.gov
• Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects#146357ClinicalTrials.gov
• Dementia Risk in Type 1 and 2 Diabetes: A Nationwide Population-Based Comparison.#159726NCBI PubMed Central
• Detecting chromatin state alterations in PBMCs associated with Type 2 Diabetes Mellitus.#159901NCBI PubMed Central
• Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina#162400ClinicalTrials.gov
• CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)#162418ClinicalTrials.gov
• Does Green Tea Affect Postprandial Glucose, Insulin and Satiety in Healthy Subjects#195481ClinicalTrials.gov
• Breaking the cycle: patient activation role in improving diabetes self-care adherence for alleviating diabetes distress.#9961PubMed
• Comparative evaluation of oxidative stress biomarkers F2-isoprostanes and 8-OHdG in Parkinson's disease and Type 2 Diabetes Mellitus: a systematic review and meta-analysis of human studies.#121227PubMed
• Reliable discrimination of type 1 and type 2 diabetes by flow-through leukocyte-endothelium interactions exploiting advanced hydrodynamic detection parameters.#1342NCBI PubMed Central
• A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263#28590ClinicalTrials.gov
• To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 Diabetes#152373ClinicalTrials.gov
• Assessment of the Efficacy of Vitamins A and D and γ-oryzanol-fortified Canola Oil in Adults With Type 2 Diabetes#162383ClinicalTrials.gov
• Real-world predictors of progression to type 2 diabetes among adults with prediabetes.#9093NCBI PubMed Central
• Detection of Type 2 Diabetes from 20-second Speech Recordings: A Large-Scale Validation Study#12988bioRxiv / medRxiv
• Latest advances and controversies of exercise therapy in the management of type 2 diabetes.#15097NCBI PubMed Central
• Palmatine ameliorates MASLD in type 2 diabetes by modulating hepatic apoptosis and inflammation.#25634NCBI PubMed Central
• Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM#28594ClinicalTrials.gov
• Dietary Reduction of AGEs to Prevent Cognitive Decline in Elderly Diabetics#67782ClinicalTrials.gov
• Metformin dosage and renal protection in type 2 diabetes mellitus: Impact on estimated glomerular filtration rate#81790PhilArchive
• Thyroid Dysfunction in Patients With Type 2 Diabetes With Early Diabetic Nephropathy.#127778ClinicalTrials.gov
• Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets#127814ClinicalTrials.gov
• Metformin Use in Chronic Kidney Disease: The CKD-Met Study#127824ClinicalTrials.gov
• Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM#136281ClinicalTrials.gov
• Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers#140940ClinicalTrials.gov
• Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell#146397ClinicalTrials.gov
• The CANTATA-MP Trial (CANagliflozin Treatment and Trial Analysis - Metformin and Pioglitazone)#148705ClinicalTrials.gov
• Heart Rate Variability in Response to Metformin Challenge#172468ClinicalTrials.gov
• To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes#172539ClinicalTrials.gov
• An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide .#175049ClinicalTrials.gov
• A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706#175060ClinicalTrials.gov
• Cinnamon Bark, Water-Soluble Cinnamon Extract, and Metformin for Treatment of Type 2 DM.#181737ClinicalTrials.gov
• Digital Quality Monitoring for Type 2 Diabetes in Swiss Primary Care: Qualitative Interview Study.#182663NCBI PubMed Central
• Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models#183842Ora Oxford University Research
• Effects of Periodontal Therapy on Systemic Inflammation#195341ClinicalTrials.gov
• A Multi-Center, Randomized, Double-Blind, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin Co-administered With Dapagliflozin Compared to Saxagliptin or Dapagliflozin All Given as add-on Therapy to Metformin in Subject With Type 2 Diabetes#18542ClinicalTrials.gov
• Study of the Effects of Vitamin C on Patients With Type 2 Diabetes#123667ClinicalTrials.gov
• Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial#141168ClinicalTrials.gov